# Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System

> **NCT07694570** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 20 (estimated)

## Conditions studied

- Atrial Fibrillation (Paroxysmal)
- Hypertension

## Interventions

- **DEVICE:** 24-hour M2VS system multimodal vital sign monitoring
- **OTHER:** Questionnaire regarding the usability and wearability

## Key facts

- **NCT ID:** NCT07694570
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-08
- **Final completion:** 2026-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694570, "Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*